2126 fundamentals
An in-depth look to JW (CAYMAN) THERAPEUTICS CO. LTD operating, investing, and financing activities
2126 free cash flow for H2 23 is -172.93 M HKD. For 2023, 2126 free cash flow was -465.23 M HKD and operating cash flow was -451.52 M HKD.
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: HKD
TTM